Follow-Up Assessments of the Pacemaker Patient

Cardiac Pacing and ICDs, Fourth Edition

Volumn , Issue , 2007, Pages 500-543

  Schoenfeld, Mark H ^a,b   Blitzer, Mark L ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HOSPITAL OF SAINT RAPHAEL   (United States)

Author keywords

Cardiac symptoms; Electrocardiogram; Follow up assessments; Magnet application; Programming

Indexed keywords

EID: 33846885582     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470750674.ch11     Document Type: Chapter

References (55)

1. Schoenfeld MH. Quality assurance in cardiac electrophysiology and pacing: a brief synopsis. Pacing Clin Electrophysiol 1994;17:267-269.
2. Schoenfeld MH. Manpower concerns in cardiac electrophysiology and pacing. Pacing Clin Electrophysiol 1995;18:1977-1979.
3. Furman S. Cardiac pacing and pacemakers: VIII. Am Heart J 1977;94:795-804.
4. Griffin JC, Schuenenemyer TD, Hess KR, et al. Pacemaker follow up: its role in the detection and correction of pacemaker system malfunction. Pacing Clin Electrophysiol 1986;9:387-391.
5. Furman S. Pacemaker follow-up. In: Furman S, Hayes DL, Holmes DR, eds. A Practice of Cardiac Pacing. 2nd ed. Mount Kisco, NY: Futura, 1989.
6. Levine PA. Proceedings of the policy conference of the North American Society of Pacing and Electrophysiology on programmability and pacemaker follow-up programs. Clin Prog Pacing Electrophysiol 1984;2:145-191.
7. DaCosta A, Kirkorian G, Cucherat M, et al. Antibiotic prophylaxis for permanent pacemaker implantation: a meta-analysis. Circulation 1998;97:1796-1801.
8. Schoenfeld MH. A primer on pacemaker programmers. Pacing Clin Electrophysiol 1993;16:2044-2052.
9. MacGregor DC, Covvey HD, Noble EJ, et al. Computer-assisted reporting system for the follow-up of patients with cardiac pacemakers. Pacing Clin Electrophysiol 1980;3:568-588.
10. Schoenfeld MH. Recommendations for implementation of a North American multicenter arrhythmia device/lead database. Pacing Clin Electrophysiol 1992;15: 1632-1636.
11. Byrd CL, Schwartz SJ, Gonzalez M, et al. Pacemaker clinic evaluations: key to early identification of surgical problems. Pacing Clin Electrophysiol 1986;9:1259-1264.
12. Hoffman A, Jost M, Pfisterer M, et al. Persisting symptoms despite permanent pacing. Incidence, causes, and follow-up. Chest 1984;85:207-210.
13. Ausubel K, Furman S. The pacemaker syndrome. Ann Intern Med 1985;103: 420-429.
14. Ellenbogen KA,Thames MD, Mohanty PK. New insights into pacemaker syndrome gained from hemodynamic, humoral and vascular responses during ventriculoatrial pacing. Am J Cardiol 1990;65:53-59.
15. Kenny RS, Sutton R. Pacemaker syndrome. BMJ 1986;293:902-903.
16. Deharo JC, Brunetto AB, Bellocci F, et al. DDDR pacing driven by contractility versus DDI pacing in vasovagal syncope: a multi-center, randomized study. Pacing Clin Electrophysiol 2003;26:447-450.
17. Connolly SJ, Sheldon R, Thorpe KE, et al. Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope: Second Vasovagal Pacemkaer Study (VPS II): a randomized trial. JAMA 2003;289:2224-2229.
18. Michaud GF, Pelosi F Jr, Noble MD, et al. A randomized trial comparing heparin initiation 6h or 24 h after pacemaker or defibrillator implantation. J Am Coll Cardiol 2000;35:1915-1918.
19. Saliba BC, Ghantous AE, Schoenfeld MH, et al.Twiddler's syndrome with transvenous defibrillators in the pectoral region. Pacing Clin Electrophysiol 1999;22:1419-1421.
20. Steiner RM, Morse D. The radiology of cardiac pacemakers. JAMA 1978;240: 2574-2576.
21. Morse D, Parsonnet V, Gessman L, et al. eds. A guide to cardiac pacemakers, defibrillators, and related products. North Carolina: Droege Computing Services; 1991.
22. Mugica J, Henry L, Rollet M, et al. The clinical utility of pacemaker follow-up visits. Pacing Clin Electrophysiol 1986;9:1249-1251.
23. Schoenfeld MH. Pacemaker programmers: an updated synopsis. Cardiac Electrophysiol Rev 1999;3:20-23.
24. Blitzer ML, Marieb MA, Schoenfeld MH. Inability to communicate with ICDs: an underreported failure mode. Pacing Clin Electrophysiol 2001;24:13-15.
25. Levine PA, Sholder J, Duncan JL. Clinical benefits of telemetered electrograms in assessment of DDD function. Pacing Clin Electrophysiol 1984;7:1170-1177.
26. Sanders R, Martin R, Fruman H, Goldberg MK. Data storage and retrieval by implantable pacemakers for diagnostic purposes. Pacing Clin Electrophysiol 1984;7: 1228-1233.
27. Sholder J, Levine PA, Mann BM, et al.Bidirectional telemetry and interrogation. In: Barold SS, Mugica J, eds. Cardiac pacing. The third decade of cardiac pacing. Mount Kisco, NY: Futura 1982:166-.
28. Duffin EG Jr. The marker channel: a telemetric diagnostic aid. Pacing Clin Electrophysiol 1984;7:1165-1169.
29. Strathmore NF, Mond HG. Noninvasive monitoring and testing of pacemaker function. Pacing Clin Electrophysiol 1987;10:1359-1370.
30. Zinberg A. Transtelephonic follow-up. Clin Prog Pacing Electrophysiol 1984;2:177.
31. Famularo MA, Kennedy HL. Ambulatory electrocardiography in the assessment of pacemaker function. Am Heart J 1982;104:1086-1094.
32. Danilovic D, Ohm OH. Pacing threshold trends and variability in modern tined leads assessed using high resolution automatic measurements: conversion of pulse width into voltage thresholds. Pacing Clin Electrophysiol 1999;22:567-587.
33. Luceri RM, Hayes DL. Follow-up of DDD pacemakers. Pacing Clin Electrophysiol 1984;7:1187-1194.
34. Schoenfeld MH, Markowitz HT. Device follow-up in the age of automaticity. Pacing Clin Electrophysiol 2000;23:803-806.
35. Wilkoff BL, Cook JR, Epstein AE, et al. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Defibrillator (DAVID) Trial. JAMA 2002;288:3115-3123.
36. Vardas PE, Simantrakis EN, Parthenakis FL, et al. AAIR versus DDDR pacing in patients with impaired sinus node chronotropy: an echocardiographic and cardiopulmonary study. Pacing Clin Electrophysiol 1997;20:1762-1768.
37. Meluzin J, Novak M, Mullerov AJ, et al. A fast and simple echocardiographic method of determination of the optimal atrioventricular delay in patients after biventricular stimulation. Pacing Clin Electrophysiol 2004;27:58-64.
38. Sogaard P, Egeblad H, Pedersen AK, et al. Sequential versus simultaneous biventricular resynchronization for severe heart failure. Circulation 2002;106:2078-2084.
39. Theuns DA, Res JC, Jordaens LJ. Home monitoring in ICD therapy: future perspectives. Europace 2003;5:139-142.
40. Schoenfeld MH, Compton SJ, Mead RH, et al. Remote monitoring of implantable cardioverter-defibrillators: a prospective analysis. Pacing Clin Electrophysiol (in press).
41. Barold SS, Schoenfeld MH. Pacemaker elective replacement indicators: latched or unlatched? Pacing Clin Electrophysiol 1989;12:990-995.
42. Barold SS, Schoenfeld MH, Falkoff MD, et al.Elective replacement indicators of simple and complex pacemakers. In: Barold SS, Mugica J, eds. New perspectives in cardiac pacing. 2nd ed. Mount Kisco, NY: Futura 1991:526-.
43. Levine PA, Barold SS, Fletcher RD, Talbot P. Adverse acute and chronic effects of electrical defibrillation and cardioversion of implanted unipolar cardiac pacing systems. J Am Coll Cardiol 1983;1:1413-1422.
44. Gimbel JR, Johnson D, Levine PA, et al. Safe performance of magnetic resonance imaging on five patients with permanent cardiac pacemakers. Pacing Clin Electrophysiol 1996;19:913-919.
45. Sommer T,Vahlhaus C, Lauck G, et al. MR imaging and cardiac pacemakers: In vitro evaluation and in vivo studies in 51 patients at 0.5T. Radiology 2000;215:869-879.
46. Cooper D, Wilkoff B, Masterson M, et al. Effects of extracorporeal shock wave lithotripsy on cardiac pacemakers and its safety in patients with implanted cardiac pacemakers. Pacing Clin Electrophysiol 1988;11:1607-1616.
47. Pinski SL, Trohman RG. Interference in implanted cardiac devices, Part 1. Pacing Clin Electrophysiol 2002;25:1367-1381.
48. Hayes DL,Wang PJ, Reynolds DW, et al. Interference with cardiac pacemakers by cellular telephones. N Engl J Med 1997;336:1473-1479.
49. Blitzer ML, Schoenfeld MH. Effects of electromagnetic interference on implanted cardiac devices. In: Raviele A, ed. Cardiac arrhythmias 2003. Milan: Springer-Verlag Italia 2004:911-918.
50. Groh WJ, Boschee SA, Engelstein ED, et al. Interactions between electronic article surveillance systems and implantable cardioverter-defibrillators. Circulation 1999; 100:387-392.
51. McIvor ME, Reddinger J, Floden E, Sheppard RC. Study of pacemaker and implantable cardioverter defibrillator triggering by electronic article surveillance devices (SPICED TEAS). Pacing Clin Electrophysiol 1998;221:1847-1861.
52. Goldschlager N, Epstein A, Friedman P, et al. Environmental and drug effects on patients with pacemakers and implantable cardioverter defibrillators. Arch Intern Med 2001;161:649-655.
53. Eriksson M, Schuller H, Sjolund B. Hazards from transcutaneous nerve stimulation in patients with pacemakers. Lancet 1978;1:1319.
54. Philbin DM, Marieb MA, Aithal KH, Schoenfeld MH. Inappropriate shocks delivered by an ICD as a result of sensed potentials from a transcutaneous electronic nerve stimulation unit. Pacing Clin Electrophysiol 1998;21:2010-2011.
55. Barold SS, Falkoff MD, Ong LS, et al. Electrocardiographic diagnoses of myocardial infarction during ventricular pacing. Cardiol Clin 1987;5:403.